Indication

Gastroenteritis due to Shigella

Gastroenteritis due to *Shigella*, commonly referred to as shigellosis or bacillary dysentery, is an acute enteric bacterial infection predominantly affecting the epithelial lining of the colon and rectum. Read more about Gastroenteritis due to Shigella

117 drugs 80 manufacturers

Advertisement

Drugs that treat it

Common Gastroenteritis due to Shigella therapies.

Showing 100–108 of 117 drugs

Filter & compare in the drug finder →Opens the drug finder with Gastroenteritis due to Shigella preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gastroenteritis due to Shigella.

Gastroenteritis due to *Shigella*, commonly referred to as shigellosis or bacillary dysentery, is an acute enteric bacterial infection predominantly affecting the epithelial lining of the colon and rectum.

It is caused by facultatively anaerobic Gram-negative bacilli of the genus *Shigella* (most notably *S.

sonnei*, *S.

flexneri*, *S.

boydii*, or *S.

dysenteriae*), which invade the colonic mucosa to trigger intense mucosal inflammation, ulceration, and fluid exudation.

Pathophysiologically characterized by an extremely low infectious dose, transmission occurs readily via the fecal-oral route.

Clinically, affected individuals—most frequently young children under 5 years of age, international travelers, and immunocompromised hosts—present with fever, abdominal cramping, tenesmus, and profuse diarrhea that typically evolves from watery stool to classic dysentery marked by small-volume stools containing blood, pus, and mucus.

Personalize your experience

Follow Gastroenteritis due to Shigella and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it